Assessments in ankylosing spondylitis

Best Practice and Research: Clinical Rheumatology

Volumn 21, Issue 4, 2007, Pages 699-712

  Zochling, Jane ^a   Braun, Jürgen ^b  

^a Menzies Centre   (Australia)

^b RHEUMAZENTRUM RUHRGEBIET   (Germany)

Author keywords

ankylosing spondylitis; ASAS core sets; outcome assessment; TNF blockers

Indexed keywords

ACUTE PHASE PROTEIN; ADALIMUMAB; ETANERCEPT; INFLIXIMAB;

ANAMNESIS; ANKYLOSING SPONDYLITIS; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; DISEASE COURSE; DRUG COST; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; HEALTH STATUS; HUMAN; JOINT EXAMINATION; JOINT RADIOGRAPHY; JOINT STIFFNESS; MEDICAL CARE; MEDICAL DOCUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHYSICAL EXAMINATION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REMISSION; REVIEW; SPINAL PAIN; SPINE MOBILITY; SYMPTOMATOLOGY; TREATMENT PLANNING; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VALIDATION STUDY;

ACUTE-PHASE PROTEINS; DISEASE PROGRESSION; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTORS;

EID: 34547480531     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2007.02.010     Document Type: Review

References (61)

1. van der Heijde D., Bellamy N., Calin A., et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. The Journal of Rheumatology 24 (1997) 2225-2229
2. van der Heijde D., van der Linden S., Dougados M., et al. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. The Journal of Rheumatology 26 (1999) 1003-1005
3. van der Heijde D., van der Linden S., Bellamy N., et al. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. The Journal of Rheumatology 26 (1999) 945-947
4. van der Heijde D., Calin A., Dougados M., et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. The Journal of Rheumatology 26 (1999) 951-954
5. Zochling J., van der Heijde D., Burgos-Vargas R., et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases 65 (2006) 442-452
6. Braun J., Pham T., Sieper J., et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases 62 (2003) 817-824
7. Braun J., Davis J., Dougados M., et al. First update of the International ASAS Consensus Statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases 65 (2006) 316-320
8. Jones S.D., Steiner A., Garrett S.L., and Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). British Journal of Rheumatology 35 (1996) 66-71
9. Pavy S., Brophy S., and Calin A. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study. The Journal of Rheumatology 32 (2005) 80-85
10. van Tubergen A., Debats I., Ryser L., et al. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis and Rheumatism 47 (2002) 242-248
11. Rudwaleit M., Metter A., Listing J., et al. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis and Rheumatism 54 (2006) 569-578
12. Salaffi F., Stancati A., Silvestri C.A., et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. European Journal of Pain (London, England) 8 (2004) 283-291
13. Garrett S., Jenkinson T., Kennedy L.G., et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. The Journal of Rheumatology 21 (1994) 2286-2291
14. Anderson J.J., Baron G., van der Heijde D., et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis and Rheumatism 44 (2001) 1876-1886
15. Haywood K.L., Garratt A.M., Jordan K., et al. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford, England) 43 (2004) 750-757
16. Viitanen J.V., Heikkila S., Kokko M.L., and Kautiainen H. Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials?. Clinical Rheumatology 19 (2000) 131-137
17. Viitanen J.V., Kokko M.L., Heikkila S., and Kautiainen H. Neck mobility assessment in ankylosing spondylitis: a clinical study of nine measurements including new tape methods for cervical rotation and lateral flexion. British Journal of Rheumatology 37 (1998) 377-381
18. Viitanen J.V., Kautiainen H., Suni J., et al. The relative value of spinal and thoracic mobility measurements in ankylosing spondylitis. Scandinavian Journal of Rheumatology 24 (1995) 94-97
19. Moll J.M., and Wright V. The pattern of chest and spinal mobility in ankylosing spondylitis. An objective clinical study of 106 patients. Rheumatology and Rehabilitation 12 (1973) 115-134
20. Macrae I.F., and Wright V. Measurement of back movement. Annals of the Rheumatic Diseases 28 (1969) 584-589
21. Macrae I.F., and Wright V. Measurement of lumbar spine motion in population studies. Annals of the Rheumatic Diseases 28 (1969) 329
22. Braun J., Cook R., Gladman D., et al. INSPIRE Lateral Flexion: a new method to measure lateral spinal mobility in patients with spondyloarthritis (abstract). Arthritis and Rheumatism 54 (2006) S476
23. Jenkinson T.R., Mallorie P.A., Whitelock H.C., et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. The Journal of Rheumatology 21 (1994) 1694-1698
24. Heuft-Dorenbosch L., Vosse D., Landewe R., et al. Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. The Journal of Rheumatology 31 (2004) 1779-1784
25. Heikkila S., Viitanen J.V., Kautiainen H., and Kauppi M. Sensitivity to change of mobility tests; effect of short term intensive physiotherapy and exercise on spinal, hip, and shoulder measurements in spondyloarthropathy. The Journal of Rheumatology 27 (2000) 1251-1256
26. Rahali-Khachlouf H., Poiraudeau S., Fermanian J., et al. Validity and reliability of spinal clinical measures in ankylosing spondylitis. Annales de réadaptation et de médecine physique 44 (2001) 205-212
27. Kennedy L.G., Jenkinson T.R., Mallorie P.A., et al. Ankylosing spondylitis: the correlation between a new metrology score and radiology. British Journal of Rheumatology 34 (1995) 767-770
28. Wanders A., Landewé R., Dougados M., et al. Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?. Annals of the Rheumatic Diseases 64 (2005) 988-994
29. van der Heijde D., Dijkmans B., Geusens P., et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis. Results of a randomized controlled trial (ASSERT). Arthritis and Rheumatism 52 (2005) 582-591
30. van Echteld I., Cieza A., Boonen A., et al. Identification of the most common problems in patients with ankylosing spondylitis using the International Classification of Functioning, Disability and Health. The Journal of Rheumatology 33 (2006) 2475-2483
31. Zochling J., Grill E., Scheuringer M., et al. Identification of health problems in patients with acute inflammatory arthritis, using the International Classification of Functioning, Disability and Health (ICF). Clinical and Experimental Rheumatology 24 (2006) 239-246
32. Sigl T., Cieza A., van der Heijde D., and Stucki G. ICF-based comparison of disease-specific instruments measuring physical functional ability for ankylosing spondylitis. Annals of the Rheumatic Diseases 64 (2005) 1576-1581
33. Calin A., Garrett S., Whitelock H., et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. The Journal of Rheumatology 21 (1994) 2281-2285
34. Dougados M., Gueguen A., Nakache J.P., et al. Evaluation of a functional index for patients with ankylosing spondylitis. The Journal of Rheumatology 17 (1990) 1254-1255
35. Robertson L.P., and Davis M.J. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology (Oxford, England) 43 (2004) 1565-1568
36. Balint P.V., Kane D., Wilson H., et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Annals of the Rheumatic Diseases 61 (2002) 905-910
37. Heuft-Dorenbosch L., Spoorenberg A., van Tubergen A., et al. Assessment of enthesitis in ankylosing spondylitis. Annals of the Rheumatic Diseases 62 (2003) 127-132
38. Braun J., Brandt J., Listing J., et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359 (2002) 1187-1193
39. Wolfe F., and Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. The Journal of Rheumatology 21 (1994) 1227-1237
40. Dougados M., Gueguen A., Nakache J.P., et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. The Journal of Rheumatology 26 (1999) 971-974
41. Dougados M., Revel M., and Khan M.A. Spondyloarthropathy treatment: progress in medical treatment, physical therapy and rehabilitation. Baillière's Clinical Rheumatology 12 (1998) 717-736
42. Spoorenberg A., van der Heijde D., de Klerk E., et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. The Journal of Rheumatology 26 (1999) 980-984
43. Ruof J., and Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. The Journal of Rheumatology 26 (1999) 966-970
44. Jones S.D., Koh W.H., Steiner A., et al. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. The Journal of Rheumatology 23 (1996) 487-490
45. van Tubergen A., Coenen J., Landewe R., et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis and Rheumatism 47 (2002) 8-16
46. Calin A., Edmunds L., and Kennedy L.G. Fatigue in ankylosing spondylitis-why is it ignored?. The Journal of Rheumatology 20 (1993) 991-995
47. Dernis-Labous E., Messow M., and Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology (Oxford, England) 42 (2003) 1523-1528
48. Heiberg M.S., Nordvag B.Y., Mikkelsen K., et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis and Rheumatism 52 (2005) 2506-2512
49. Cella D., Lai J.S., Chang C.H., et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94 (2002) 528-538
50. Smets E.M., Garssen B., Bonke B., and De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 39 (1995) 315-325
51. Dagfinrud H., Vollestad N.K., Loge J.H., et al. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures. Arthritis and Rheumatism 53 (2005) 5-11
52. Zochling J., van der Heijde D., Dougados M., and Braun J. Current evidence for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases 65 (2006) 423-432
53. Creemers M.C.W., Franssen M.J.A.M., van 't Hof M.A., et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Annals of the Rheumatic Diseases 64 (2005) 127-129
54. Braun J., Bollow M., and Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheumatic Diseases Clinics of North America 24 (1998) 697-735
55. Braun J., Bollow M., Eggens U., et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis and Rheumatism 37 (1994) 1039-1045
56. Zochling J., and Braun J. Remission in ankylosing spondylitis. Clinical and Experimental Rheumatology 24 (2006) S088-S092
57. Calin A., Nakache J.P., Gueguen A., et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?. Rheumatology (Oxford, England) 38 (1999) 878-882
58. Haywood K.L., Garratt A.M., and Dawes P.T. Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford, England) 44 (2005) 577-586
59. Cohen J.D., Cunin P., Farrenq V., et al. Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies. The Journal of Rheumatology 33 (2006) 79-81
60. Breban M., Vignon E., Claudepierre P., et al. Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology 41 (2002) 1280-1285
61. Ward M.M. Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?. Annals of the Rheumatic Diseases 65 supplement 3 (2006) iii25-iii28